skip to main content
Idioma:
Refinado por: Nome da Publicação: Alimentary Pharmacology & Therapeutics remover assunto: Life Sciences & Biomedicine remover Double-Blind Method remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Specific inhibition of cyclooxygenase‐2 with MK‐0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen
Specific inhibition of cyclooxygenase‐2 with MK‐0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen
Material Type:
Artigo 		Adicionar ao Meu Espaço

Specific inhibition of cyclooxygenase‐2 with MK‐0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen

Lanza, F. L. ; Rack, M. F. ; Simon, T. J. ; Quan, H. ; Bolognese, J. A. ; Hoover, M. E. ; Wilson, F. R. ; Harper, S. E.

Alimentary pharmacology & therapeutics, 1999-06, Vol.13 (6), p.761-767 [Periódico revisado por pares]

Oxford UK: Blackwell Science Ltd

Texto completo disponível

Citações Citado por
2
Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials
Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials

Hawkey, C. J. ; Laine, L. ; Harper, S. E. ; Quan, H. U. I. ; Bolognese, J. A. ; Mortensen, E.

Alimentary pharmacology & therapeutics, 2001-10, Vol.15 (10), p.1593-1601 [Periódico revisado por pares]

Oxford UK: Blackwell Science Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.